@dilucadaniel.bsky.social
Thanks for highlighting our research, @michaelokun.bsky.social
Wonderful interpretation and contextualization of our study. And yes! As opposed to the traditional knowledge, we night be able to reduce medications in GPi DBS!
@WashUNeurology @movedisorder @MDCP_Journal
Wonderful interpretation and contextualization of our study. And yes! As opposed to the traditional knowledge, we night be able to reduce medications in GPi DBS!
@WashUNeurology @movedisorder @MDCP_Journal
Is it a myth that you cannot reduce medications following GPi DBS? Yep. Connectomic imaging reveals to us the potential reason(s) why in some cases you can reduce medications post GPi DBS. Di Luca/colleagues challenge the conventional wisdom that medication reduction only occurs following STN.
March 20, 2025 at 3:43 PM
Thanks for highlighting our research, @michaelokun.bsky.social
Wonderful interpretation and contextualization of our study. And yes! As opposed to the traditional knowledge, we night be able to reduce medications in GPi DBS!
@WashUNeurology @movedisorder @MDCP_Journal
Wonderful interpretation and contextualization of our study. And yes! As opposed to the traditional knowledge, we night be able to reduce medications in GPi DBS!
@WashUNeurology @movedisorder @MDCP_Journal
Reposted
Our review 'Update on the Treatment of Autonomic Disorders' just got published. We discuss non-pharmacological, pharmacological, and neuromodulatory and device options for autonomic disorders in a very clinic-oriented way. This is an important topic for neurologists and primary care physicians.
Update on the Treatment of Autonomic Disorders - Current Treatment Options in Neurology
Purposeof Review Autonomic disorders disrupt homeostasis and cause symptoms such as orthostatic hypotension, urinary urgency, bladder overfilling, sexual dysfunction, constipation, and gastroparesis. ...
link.springer.com
March 16, 2025 at 6:08 PM
Our review 'Update on the Treatment of Autonomic Disorders' just got published. We discuss non-pharmacological, pharmacological, and neuromodulatory and device options for autonomic disorders in a very clinic-oriented way. This is an important topic for neurologists and primary care physicians.